Estradiol (E2) Blood Test - NBI
Estradiol (E2) Blood Test - NBI

Estradiol (E2) Blood Test

Regular price $41.00

Estradiol is one of the three many types of estrogen. The other two are estrone and estriol. Estradiol is produced in the body by testosterone. Estradiol (E2) is the most potent form of estrogen and is produced by the ovaries. Estradiol is measured to assess for menstrual problems, fertility issues, menopause status or as a tumor marker in patients with cancer. When estradiol decreases after menopause, it can lead to an increase in bone loss and can cause osteoporosis.

What’s Reported
  • Estradiol

Methodology: Immunoassay (IA)

How to prepare

Fasting: No.

Water: Drink plenty of water to stay well hydrated.

Medications: Take all medications as prescribed.

Dietary supplements: If you take a dietary supplement containing Vitamin D, discontinue the dietary supplement 48 hours (two days) prior to the blood test. This will give a more realistic picture of a person’s Vitamin D status.

How long until you get the results

2 business days
Result turnaround times are estimates and not guaranteed. Due to factors outside of our control, such as weather, holidays, confirmation/repeat testing or equipment maintenance, our lab may require additional time to complete tests.

More about this test

While women and men both produce estradiol, women make a lot more of it. Estradiol is an important in female reproductive system. It increases during puberty and is important for fertility and reproduction. But estradiol has many other roles. It is a potent antiinflammatory chemical.

Low estradiol can create:

  • Decreased quality of life
  • Depression
  • Heart disease
  • Hot flashes
  • Insomnia
  • Low libido
  • Osteoporosis
  • Ovarian failure
  • Poor blood sugar control and increased diabetes risk
  • Vaginal dryness
References

Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med. 2006;119(5):426-433.

Arevalo MA, Azcoitia I, Garcia-Segura LM. The neuroprotective actions of oestradiol and oestrogen receptors. Nat Rev Neurosci. 2015;16(1):17-29.

Fait T. Menopause hormone therapy: latest developments and clinical practice. Drugs Context. 2019;8:212551.

Yilmaz C, Karali K, Fodelianaki G, et al. Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol. 2019:100788.